dronabinol has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentur, OS; Hochner, O; Ingbir, M; Porat, R; Szekely, Y | 1 |
| Chai, SY; Chen, CJ; Li, YN; Li, YY; Lv, S; Ni, JB; Storr, M; Wu, RH; Yüce, B | 1 |
2 other study(ies) available for dronabinol and Blood Poisoning
| Article | Year |
|---|---|
Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model.
Topics: Anti-Inflammatory Agents; Biological Products; Cannabinoids; Cells, Cultured; Cytokine Release Syndrome; Cytokines; Dose-Response Relationship, Drug; Dronabinol; Humans; Inflammation Mediators; Lipopolysaccharides; Sepsis | 2020 |
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus.
Topics: Analysis of Variance; Animals; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Electrophysiology; Enzyme-Linked Immunosorbent Assay; Gastrointestinal Motility; Gastrointestinal Transit; Ileus; Interleukin-6; Jejunal Diseases; Jejunum; Lipopolysaccharides; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sepsis; Tumor Necrosis Factor-alpha | 2010 |